ea0049ep620 | Diabetes therapy | ECE2017
, Evren Bahri
, Kara Mahmut
, Yucel Seyfullah
, Sahin Ibrahim
Introduction: Incretin based therapeutics have commonly been used in the last years for the management of patients with type 2 diabetes mellitus (DM). Linagliptin is a member of dipeptidyl peptidase 4 (DPP-4) inhibitors and often preferred owing to some advantages over the others. We present a diabetic case developing skin findings after the initiation of linagliptin.Case: 66 year-old woman with a history of type 2 DM for 10 years was admitte...